Assessment circulating micro-RNA-192 in Egyptian patients with non-viral liver cirrhosis and hepatocellular carcinoma.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
92 participants were allocated into four equal groups (n = 23): control, compensated liver cirrhosis, decompensated cirrhosis, and HCC groups.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[RESULTS] Decompensated cirrhosis and HCC showed significantly elevated Serum Alanine aminotransferase, aspartate aminotransferase, bilirubin, alpha-fetoprotein, and microRNA-192. [CONCLUSION] Serum microRNA-192 can predict decompensated liver cirrhosis and HCC with high sensitivity and specificity.
[BACKGROUND] It is challenging to diagnose hepatic cirrhosis and hepatocellular carcinoma (HCC) at an early stage since non-invasive markers are not specific and do not identify the early stage.
- 표본수 (n) 23
APA
Abdelaziz MA, Elagali AM, et al. (2026). Assessment circulating micro-RNA-192 in Egyptian patients with non-viral liver cirrhosis and hepatocellular carcinoma.. Discover oncology, 17(1), 153. https://doi.org/10.1007/s12672-025-04304-2
MLA
Abdelaziz MA, et al.. "Assessment circulating micro-RNA-192 in Egyptian patients with non-viral liver cirrhosis and hepatocellular carcinoma.." Discover oncology, vol. 17, no. 1, 2026, pp. 153.
PMID
41575695 ↗
Abstract 한글 요약
[BACKGROUND] It is challenging to diagnose hepatic cirrhosis and hepatocellular carcinoma (HCC) at an early stage since non-invasive markers are not specific and do not identify the early stage.
[OBJECTIVE] Serum microRNA-192 could represent an early and critical pathogenetic factor in different liver diseases.
[METHODS] 92 participants were allocated into four equal groups (n = 23): control, compensated liver cirrhosis, decompensated cirrhosis, and HCC groups.
[RESULTS] Decompensated cirrhosis and HCC showed significantly elevated Serum Alanine aminotransferase, aspartate aminotransferase, bilirubin, alpha-fetoprotein, and microRNA-192.
[CONCLUSION] Serum microRNA-192 can predict decompensated liver cirrhosis and HCC with high sensitivity and specificity.
[OBJECTIVE] Serum microRNA-192 could represent an early and critical pathogenetic factor in different liver diseases.
[METHODS] 92 participants were allocated into four equal groups (n = 23): control, compensated liver cirrhosis, decompensated cirrhosis, and HCC groups.
[RESULTS] Decompensated cirrhosis and HCC showed significantly elevated Serum Alanine aminotransferase, aspartate aminotransferase, bilirubin, alpha-fetoprotein, and microRNA-192.
[CONCLUSION] Serum microRNA-192 can predict decompensated liver cirrhosis and HCC with high sensitivity and specificity.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Mandibular Metastasis as the Initial Presentation of Hepatoid Adenocarcinoma of the Lung: A Case Report.
- Concurrent hepatic cirrhosis and chronic lymphocytic leukemia: a challenging coexistence: a case report.
- Recurrence of gastric cancer with Krukenberg tumor, presenting with a high alpha-fetoprotein level, a case report.
- Serum protein induced by vitamin K absence or antagonist-II predicts aggressive tumor biology in alpha-fetoprotein-normal hepatocellular carcinoma.
- Practice changing RCT design and rationale: Abbreviated MRI plus AFP ultrasound plus AFP for HCC surveillance in cirrhosis (PREMIUM study).
- The Impact of Diffuse Liver Disease on Liver Lesion Detection and Characterization.